Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression.

[1]  C. Snehalatha,et al.  Beneficial effects of strategies for primary prevention of diabetes on cardiovascular risk factors: results of the Indian Diabetes Prevention Programme , 2008, Diabetes & vascular disease research.

[2]  S. Yano,et al.  Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells , 2007, BMC Cell Biology.

[3]  G. Hawker,et al.  The Risk of Hip Fractures in Older Individuals With Diabetes , 2007, Diabetes Care.

[4]  P. Vestergaard,et al.  Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.

[5]  J. Zierath,et al.  AMP-activated protein kinase signaling in metabolic regulation. , 2006, The Journal of clinical investigation.

[6]  A. Cortizo,et al.  Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture. , 2006, European journal of pharmacology.

[7]  J. Cauley,et al.  Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. , 2005, Archives of internal medicine.

[8]  N. Fujii,et al.  Symposium 1 : Exercise signalling pathways controlling fuel oxidation during and after exercise Regulation of glucose transport by the AMP-activated protein kinase , 2004 .

[9]  J. Buse,et al.  The effects of oral anti‐hyperglycaemic medications on serum lipid profiles in patients with type 2 diabetes , 2004, Diabetes, obesity & metabolism.

[10]  Janet Rubin,et al.  Mechanical Strain Differentially Regulates Endothelial Nitric-oxide Synthase and Receptor Activator of Nuclear κB Ligand Expression via ERK1/2 MAPK* , 2003, Journal of Biological Chemistry.

[11]  D. Pipeleers,et al.  AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. , 2003, Journal of molecular endocrinology.

[12]  D. Pipeleers,et al.  AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase , 2003, Diabetologia.

[13]  H. Yoshikawa,et al.  Continuous Inhibition of MAPK Signaling Promotes the Early Osteoblastic Differentiation and Mineralization of the Extracellular Matrix , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  Olle Ljunqvist,et al.  Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. , 2002, Diabetes.

[15]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[16]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[17]  S. Ralston,et al.  Nitric oxide and bone , 2001, Immunology.

[18]  G. Mundy,et al.  Statins and bone formation. , 2001, Current pharmaceutical design.

[19]  Su‐Li Cheng,et al.  Erk Is Essential for Growth, Differentiation, Integrin Expression, and Cell Function in Human Osteoblastic Cells* , 2001, The Journal of Biological Chemistry.

[20]  D. Reid,et al.  Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase. , 2001, Endocrinology.

[21]  S. Harris,et al.  Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.

[22]  P. Ortiz de Montellano,et al.  AMP‐activated protein kinase phosphorylation of endothelial NO synthase , 1999, FEBS letters.

[23]  U. Laufs,et al.  Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. , 1998, Circulation.

[24]  L. Bonewald,et al.  Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long‐term cultures of fetal rat calvarial osteoblasts , 1994 .

[25]  E. Barrett-Connor,et al.  Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitus. , 1992, JAMA.

[26]  Y. Amagai,et al.  In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria , 1983, The Journal of cell biology.

[27]  Z. Beg,et al.  Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and wth protein fractions of rat liver cytosol. , 1973, Biochemical and biophysical research communications.

[28]  O. H. Lowry,et al.  The quantitative histochemistry of brain. II. Enzyme measurements. , 1954, The Journal of biological chemistry.

[29]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.